These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8739277)

  • 1. Effectiveness of intravenous administration of Fe-gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients.
    Navarro JF; Teruel JL; Liaño F; Marcén R; Ortuño J
    Am J Nephrol; 1996; 16(4):268-72. PubMed ID: 8739277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intravenous sodium ferric gluconate improves efficacy in the maintenance phase of EPOrHu administration in hemodialysis patients.
    Bolaños L; Castro P; Falcón TG; Mouzo R; Varela JM
    Am J Nephrol; 2002; 22(1):67-72. PubMed ID: 11919405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
    Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of body iron stores on the serum erythropoietin concentration in hemodialyzed patients.
    Teruel JL; Marcen R; Navarro JF; Villafruela JJ; Fernandez Lucas M; Rivera M; Ortuño J
    Am J Nephrol; 1994; 14(2):95-8. PubMed ID: 8080013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two iron gluconate treatment modalities in chronic hemodialysis patients: results of a randomized trial.
    Giordano A; Arrigo G; Lavarda F; Colasanti G; Petrini C
    J Nephrol; 2005; 18(2):181-7. PubMed ID: 15931646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
    Harmankaya O; Eran A
    Ren Fail; 2002 Mar; 24(2):245-7. PubMed ID: 12071600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE; Peat N; Porter C; Morgan AG
    Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron supplementation in adolescent hemodialysis patients.
    Nailescu C; Castaneda M; Del Rio M; Flynn JT
    Clin Nephrol; 2004 Dec; 62(6):449-54. PubMed ID: 15630904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
    Yorgin PD; Belson A; Sarwal M; Alexander SR
    Pediatr Nephrol; 2000 Dec; 15(3-4):171-5. PubMed ID: 11149105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
    Warady BA; Zobrist RH; Wu J; Finan E;
    Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
    Tarng DC; Huang TP; Chen TW
    Am J Nephrol; 1997; 17(2):158-64. PubMed ID: 9096447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
    Coyne DW; Kapoian T; Suki W; Singh AK; Moran JE; Dahl NV; Rizkala AR;
    J Am Soc Nephrol; 2007 Mar; 18(3):975-84. PubMed ID: 17267740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight iron dextran in the management of renal anaemia in patients on haemodialysis--the IDIRA Study.
    Rath T; Florschütz K; Kalb K; Rothenpieler U; Schletter J; Seeger W; Zinn S
    Nephron Clin Pract; 2010; 114(1):c81-8. PubMed ID: 19887827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ferric saccharate as an iron supplement in dialysis patients.
    Silverberg DS; Blum M; Peer G; Kaplan E; Iaina A
    Nephron; 1996; 72(3):413-7. PubMed ID: 8852489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.